Abgent is a biotech company manufacturing primary antibodies with more than a decade of experience. Most of Abgent’s antibodies are produced in-house to ensure high specificity, affinity, and reproducibility.
Abgent is a biotech company manufacturing primary antibodies with more than a decade of experience. Most of Abgent’s antibodies are produced in-house to ensure high specificity, affinity, and reproducibility.
Arthus Biosystems is a biotech company providing a unique series of tools against S-adenosylmethionine (SAM, AdeMet, SAMe) and S-adenosylhomocysteine (SAH).
Immunodiagnostic Systems (IDS) is a biotech company dedicated to the development of innovative immunoassays and automated immunoanalyser technologies for the determination of both 25-Hydroxy Vitamin D and 1,25-Dihydroxy Vitamin D.
Syngene is a biotech company offering a wide range of equipment for instant gel documentation, automated chemiluminescence imaging and TLC plate reading.
One World Lab aims to simplify the antibody validation process by providing access to smaller aliquot sizes for testing and bringing multiple vendors together in a single place. Thus, One World Lab offers low-cost, validation size aliquots for comparison.
Premier Biosoft is a biotech company dedicated to accelerating research in life sciences. Premier Biosoft studies the most recent innovations in biology research and translates them into software products to aid researchers worldwide.
Cancer Research Technology is a biotech company specialized in the field of cancer research and development, including 30 years’ specialist experience in the commercialization of cancer research tools.
Biorbyt is a biotech company specialized in custom peptide synthesis and custom His-tag protein production.
Zenith Epigenetics is a biotech company developing bromodomain (BET) inhibitors for the treatment of cancer and autoimmune disorders. Zenith Epigenetics aims to become a leading epigenetic company translating bromodomain biology into impactful therapies.
Somalogic is biotech company using its proprietary Slow Off-rate Modified Aptamer (“SOMAmer”) technology along with its unbiased biomarker discovery assay (SOMAscan) to develop new proteomics tools.